Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) be Used as Inflammatory Markers to Predict Length of Hospital Stay After Total Laparoscopic Hysterectomy (TLH) for Benign Indications?

NCT05003297 is registered in ClinicalTrials.gov with Gaziosmanpasa Research and Education Hospital as lead sponsor.

NCT NCT05003297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05003297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) be Used as Inflammatory Markers to Predict Length of Hospital Stay After Total Laparoscopic Hysterectomy (TLH) for Benign Indications?
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
December 30, 2018
Enrollment
150 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hospital stay, inflammation, total laparoscopic hysterectomy